Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/116147

Documents

In Collections

This item can be found in the following collections:

Weinblatt, M.E.; Bingham, C.O.; Burmester, G.R.; Bykerk, V.P.; Furst, D.E.; Mariette, X.; ... ; Emery, P. (2017)

A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis

Article / Letter to editor
All authors
Weinblatt, M.E.; Bingham, C.O.; Burmester, G.R.; Bykerk, V.P.; Furst, D.E.; Mariette, X.; Heijde, D. van der; Vollenhoven, R. van; VanLunen, B.; Ecoffet, C.; Cioffi, C.; Emery, P.
Date
2017-10-31
Journal
Arthritis and Rheumatology
Volume
69
Issue
10
Pages
1937 - 1948
DOI
doi:10.1002/art.40196